Hepatology (Baltimore, Md.)
Integrative hepatology: Enhancing overall health to manage liver disease.
Salivary microbiome and serum metabolomics add to clinical biomarkers to predict 6-month hospitalizations in a multicenter cirrhosis outpatient cohort.
Reply: Considerations on the use of LPCN 1148 in cirrhotic patients with sarcopenia.
The Liver Transplant Comorbidity Index (LTCI) : A composite index of ambulatory Pre-LT factors to identify patients at increased risk of Post-LT Mortality.
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction.
Reply: Downstaging of hepatocellular carcinoma before liver transplantation.
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multi-center prospective cohort study.
Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial.
Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4.
